Skip to main content
. 2021 Jul 21;12:710747. doi: 10.3389/fmicb.2021.710747

Figure 2.

Figure 2

ESBL/AmpC-EC showed significantly higher resistance rate to antibiotics compared to non-ESBL/AmpC-EC. Statistically significant (*p < 0.05, GEE; p < 0.05, Chi-square test).